Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? DEFICIT (Details Narrative)

STOCKHOLDERS’ DEFICIT (Details Narrative)									1 Months Ended	2 Months Ended	3 Months Ended		8 Months Ended	9 Months Ended		12 Months Ended
STOCKHOLDERS’ DEFICIT (Details Narrative)	Apr. 05, 2022 USD ($) $ / shares shares	Feb. 17, 2022 USD ($) $ / shares shares	Jan. 24, 2022 USD ($) $ / shares shares	Jan. 20, 2022 USD ($) $ / shares shares	Nov. 30, 2021 USD ($) $ / shares shares	Aug. 12, 2021 USD ($) $ / shares shares	Jul. 20, 2021 USD ($) $ / shares shares	Nov. 17, 2020	Sep. 30, 2021 USD ($) $ / shares shares	May 31, 2022 USD ($) $ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Mar. 31, 2021 USD ($)	Mar. 22, 2022 USD ($) shares	Mar. 31, 2022 USD ($) $ / shares shares	Mar. 31, 2021 USD ($) shares	Jun. 30, 2021 USD ($) $ / shares shares	Apr. 30, 2022 shares	Apr. 13, 2022 USD ($) $ / shares	Mar. 31, 2022 AUD ($) shares	Aug. 12, 2021 AUD ($)	Jun. 30, 2021 AUD ($) shares	Feb. 04, 2020 shares	Feb. 03, 2020 shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares authorized \| shares											1,000,000,000			1,000,000,000		1,000,000,000			1,000,000,000		1,000,000,000	1,000,000,000	100,000,000
Reverse stock split								one-for-one thousand
Preferred stock shares authorized \| shares											1,500,005			1,500,005		1,500,005			1,500,005		1,500,005
Preferred stock per share value \| $ / shares											$ 0.01			$ 0.01		$ 0.01
Issuance of stock \| shares														18,599,907
Common stock value											$ 85,030			$ 85,030		$ 14,056
Interest payable current and non current											57,561			57,561		34,098
Share based compensation											$ 20,718	$ 20,718		$ 62,154	$ 62,154
Share price \| $ / shares											$ 0.0156			$ 0.0156
Accrued salaries current											$ 29,217			$ 29,217		$ 101,250			$ 40,500		$ 135,000
Common stock shares issued \| shares											85,030,026			85,030,026		14,055,393			85,030,026		14,055,393
Deemed dividend											$ 237,389			$ 445,631
Stock option expense														$ 10,359
Term of warrant											1 month 13 days			1 month 13 days					1 month 13 days
93 Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares											$ 200			$ 200
Warrants exercise price \| $ / shares											0.001			0.001
Warrants exercise price \| $ / shares											200			$ 200
Fourty Four Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of exercise price and market price														70.00%
Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of stock \| shares	4,242,998									13,136,082
Shares issued price per share \| $ / shares	$ 0.02
Debt instrument contractual conversion price \| $ / shares										$ 0.01
Debt instrument face amount										$ 93,500
Interest payable current and non current										5,100
Proceeds from issuance of common stock	$ 66,106
Premiums to additional paid in capital										$ 50,346
Chief Scientific Officer and Director [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock value						$ 107,388
Shares issued price per share \| $ / shares						$ 0.03
Stock issued during period shares employee benefit plan \| shares						3,420,000
Share based compensation														$ 4,788
Adjustments to additional paid in capital stock issued issuance costs														102,600
Mr. Nathanielsz [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation														8,299
Adjustments to additional paid in capital stock issued issuance costs														177,840
Legal Services [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock value				$ 20,000
Shares issued price per share \| $ / shares				$ 0.03
Stock issued during period shares employee benefit plan \| shares				666,667
Share based compensation														20,000
Legal Services [Member] \| Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock value																		$ 46,771
Shares issued price per share \| $ / shares																		$ 0.01
Consultant Services [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock value			$ 45,030
Shares issued price per share \| $ / shares			$ 0.02
Stock issued during period shares employee benefit plan \| shares			2,274,224
Share based compensation														$ 45,030
Convertible Debt [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of stock \| shares														30,488,831
Debt instrument contractual conversion price \| $ / shares											$ 0.02			$ 0.02
Debt instrument face amount											$ 392,599			$ 392,599
Interest payable current and non current											22,031			22,031
Conversion fees											2,250			2,250
Proceeds from issuance of common stock														416,880
Premiums to additional paid in capital														227,150
Consulting Agreement [Member] \| Consultant Services [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation														24,000
Nathanielsz Cancellation Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of bonus of annual base salary						200.00%
Nathanielsz Cancellation Agreement [Member] \| Mr. Nathanielsz [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock value							$ 186,139
Percentage of bonus of annual base salary							78.00%
Officers compensation							$ 177,840
Debt conversion converted instrument shares issued \| shares							5,928,000
Share price \| $ / shares							$ 0.03
Cancellation Agreement [Member] \| Deferred Salary [Member] \| Chief Scientific Officer and Director [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accrued salaries current						$ 102,600
Director Agreement [Member] \| Josef Zelinger [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of stock \| shares																2,800,000
Common stock value																$ 87,920
Share based compensation														3,920
Share price \| $ / shares																$ 0.03
Adjustments to additional paid in capital stock issued issuance costs														84,000
Accrued salaries current						$ 184														$ 250.00
Accrued liabilities																$ 84,000
Dutchess [Member] \| Common Stock Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Agreement term					36 months
Lowest trading price					92.00%
Percentage of average daily trading volume					300.00%
Common stock value					$ 250,000
Deferred offering cost											$ 20,000			$ 20,000
Dutchess [Member] \| Common Stock Purchase Agreement [Member] \| Restricted Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock value					$ 20,000
Restricted shares of common stock \| shares					1,000,000
Shares issued price per share \| $ / shares					$ 0.02
Maximum [Member] \| Convertible Debt [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument contractual conversion price \| $ / shares											$ 0.04			$ 0.04
Maximum [Member] \| Dutchess [Member] \| Common Stock Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, value					$ 5,000,000
Minimum [Member] \| Convertible Debt [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument contractual conversion price \| $ / shares											$ 0.01			$ 0.01
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock shares authorized \| shares											500,000			500,000		500,000			500,000		500,000
Preferred stock per share value \| $ / shares											$ 0.01			$ 0.01		$ 0.01
Preferred stock shares issued \| shares											500,000			500,000		500,000			500,000		500,000
Preferred stock shares outstanding \| shares											500,000			500,000		500,000			500,000		500,000
Issuance of stock \| shares														0	0
Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock shares authorized \| shares											5			5		5			5		5
Preferred stock per share value \| $ / shares											$ 0.01			$ 0.01		$ 0.01
Preferred stock shares issued \| shares											1			1		1			1		1
Preferred stock shares outstanding \| shares											1			1		1			1		1
Issuance of stock \| shares														0	0
Series B Preferred Stock [Member] \| Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock shares authorized \| shares											5			5					5
Series B Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from issuance of warrants													$ 475,000
Exercise of warrants \| shares													11,875
Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock shares authorized \| shares											1,500,005			1,500,005					1,500,005
Preferred stock per share value \| $ / shares											$ 0.01			$ 0.01
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of stock \| shares						2,800,000
Common stock value						$ 87,920
Shares issued price per share \| $ / shares						$ 0.03
Stock issued during period shares employee benefit plan \| shares						2,800,000
Bonus payable											$ 84,000			$ 84,000		$ 84,000
Share based compensation														$ 3,920
Common stock shares issued \| shares											1,250		10,625	1,250					1,250
Common Stock [Member] \| Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares issued \| shares																	1,250
Common Stock [Member] \| Legal Services [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock value		$ 24,000				$ 7,883
Shares issued price per share \| $ / shares		$ 0.02				$ 0.05
Stock issued during period shares employee benefit plan \| shares		1,148,326				166,667
Share based compensation														$ 7,883
Common Stock [Member] \| Consultant Services [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock value									$ 104,611
Shares issued price per share \| $ / shares									$ 0.04
Stock issued during period shares employee benefit plan \| shares									2,819,712
Share based compensation														$ 104,611
Common Stock [Member] \| Underlying Financing Agreements [Member] \| Convertible Debt [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock reserved for future issuance \| shares											272,862,892			272,862,892					272,862,892